InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Sonoma Pharmaceuticals, Inc.

SNOA Clue Score50
United States Fiscal year ends March CIK 0001367083
$1.23 +6.03% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.23 −77.39% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue12.8Operating income−13.0Net income9.3Fiscal year 2018Revenue16.7 +29.9%Operating income−14.2Net income−14.3 −254.5%Fiscal year 2019Revenue19.0 +13.9%Operating income−11.3Net income−11.8Fiscal year 2020Revenue17.9 −5.5%Operating income−7.4Net income−3.3Fiscal year 2021Revenue18.6 +3.9%Operating income−3.4Net income−4.0Fiscal year 2022Revenue12.6 −32.2%Operating income−5.9Net income−5.1EPS, diluted−1.92Fiscal year 2023Revenue13.3 +5.1%Operating income−4.6Net income−5.2EPS, diluted−1.52Fiscal year 2024Revenue12.7 −4.0%Operating income−4.7Net income−4.8EPS, diluted−10.63Fiscal year 2025Revenue14.3 +12.2%Operating income−3.7Net income−3.5EPS, diluted−2.79Fiscal year 2026Revenue19.5 +36.7%Operating income−2.5Net income−3.2EPS, diluted−1.89
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 12.8 16.7 19.0 17.9 18.6 12.6 13.3 12.7 14.3 19.5
Growth +29.9% +13.9% −5.5% +3.9% −32.2% +5.1% −4.0% +12.2% +36.7%
Operating income −13.0 −14.2 −11.3 −7.4 −3.4 −5.9 −4.6 −4.7 −3.7 −2.5
Net income 9.3 −14.3 −11.8 −3.3 −4.0 −5.1 −5.2 −4.8 −3.5 −3.2
Growth −254.5%
EPS, diluted n/a n/a n/a n/a n/a −1.92 −1.52 −10.63 −2.79 −1.89

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin44.2%Operating margin−101.2%Net margin72.3%Free cash flow margin−66.8%Fiscal year 2018Gross margin43.9%Operating margin−85.2%Net margin−86.0%Free cash flow margin−75.8%Fiscal year 2019Gross margin46.8%Operating margin−59.3%Net margin−62.2%Free cash flow margin−62.3%Fiscal year 2020Gross margin45.3%Operating margin−41.2%Net margin−18.5%Free cash flow margin−26.8%Fiscal year 2021Gross margin35.2%Operating margin−18.5%Net margin−21.2%Free cash flow margin−19.1%Fiscal year 2022Gross margin31.6%Operating margin−46.6%Net margin−40.3%Free cash flow margin−34.7%Fiscal year 2023Gross margin33.7%Operating margin−34.4%Net margin−38.8%Free cash flow margin−48.4%Fiscal year 2024Gross margin37.3%Operating margin−36.9%Net margin−38.0%Free cash flow margin−18.8%Fiscal year 2025Gross margin38.2%Operating margin−26.0%Net margin−24.2%Free cash flow margin−1.2%Fiscal year 2026Gross margin38.0%Operating margin−12.6%Net margin−16.3%Free cash flow margin−21.1%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Gross margin 44.2% 43.9% 46.8% 45.3% 35.2% 31.6% 33.7% 37.3% 38.2% 38.0%
Operating margin −101.2% −85.2% −59.3% −41.2% −18.5% −46.6% −34.4% −36.9% −26.0% −12.6%
Net margin 72.3% −86.0% −62.2% −18.5% −21.2% −40.3% −38.8% −38.0% −24.2% −16.3%
Free cash flow margin −66.8% −75.8% −62.3% −26.8% −19.1% −34.7% −48.4% −18.8% −1.2% −21.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−8.2Capital expenditure−0.4Free cash flow−8.6Fiscal year 2018Operating cash flow−12.4Capital expenditure−0.2Free cash flow−12.6Fiscal year 2019Operating cash flow−11.7Capital expenditure−0.1Free cash flow−11.8Fiscal year 2020Operating cash flow−4.6Capital expenditure−0.2Free cash flow−4.8Fiscal year 2021Operating cash flow−3.4Capital expenditure−0.2Free cash flow−3.6Fiscal year 2022Operating cash flow−4.2Capital expenditure−0.1Free cash flow−4.4Fiscal year 2023Operating cash flow−6.2Capital expenditure−0.3Free cash flow−6.4Fiscal year 2024Operating cash flow−2.4Capital expenditure−0.0Free cash flow−2.4Fiscal year 2025Operating cash flow−0.1Capital expenditure−0.1Free cash flow−0.2Fiscal year 2026Operating cash flow−3.9Capital expenditure−0.2Free cash flow−4.1
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −8.2 −12.4 −11.7 −4.6 −3.4 −4.2 −6.2 −2.4 −0.1 −3.9
Capital expenditure −0.4 −0.2 −0.1 −0.2 −0.2 −0.1 −0.3 −0.0 −0.1 −0.2
Free cash flow −8.6 −12.6 −11.8 −4.8 −3.6 −4.4 −6.4 −2.4 −0.2 −4.1
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash17.5Total debt0.2Net cash (debt)17.3Shareholders’ equity21.4Debt to equity0.01Fiscal year 2018Cash10.1Total debt0.3Net cash (debt)9.8Shareholders’ equity15.3Debt to equity0.02Fiscal year 2019Cash3.7Total debt0.3Net cash (debt)3.4Shareholders’ equity7.8Debt to equity0.04Fiscal year 2020Cash3.7Total debt0.5Net cash (debt)3.2Shareholders’ equity5.6Debt to equity0.09Fiscal year 2021Cash4.2Total debt1.9Net cash (debt)2.3Shareholders’ equity5.4Debt to equity0.36Fiscal year 2022Cash7.4Total debt0.0Net cash (debt)7.4Shareholders’ equity8.7Debt to equity0.00Fiscal year 2023Cash3.8Shareholders’ equity8.0Fiscal year 2024Cash3.1Shareholders’ equity6.1Fiscal year 2025Cash5.4Shareholders’ equity4.4Fiscal year 2026Cash2.4Shareholders’ equity3.1
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 17.5 10.1 3.7 3.7 4.2 7.4 3.8 3.1 5.4 2.4
Total debt 0.2 0.3 0.3 0.5 1.9 0.0 n/a n/a n/a n/a
Net cash (debt) 17.3 9.8 3.4 3.2 2.3 7.4 n/a n/a n/a n/a
Shareholders’ equity 21.4 15.3 7.8 5.6 5.4 8.7 8.0 6.1 4.4 3.1
Debt to equity 0.01 0.02 0.04 0.09 0.36 0.00 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Mar 2017 FY2018 31 Mar 2018 FY2019 31 Mar 2019 FY2020 31 Mar 2020 FY2021 31 Mar 2021 FY2022 31 Mar 2022 FY2023† 31 Mar 2023 FY2024† 31 Mar 2024 FY2025† 31 Mar 2025 FY2026 31 Mar 2026
Revenue and profit
12.8 16.7 19.0 17.9 18.6 12.6 13.3 12.7 14.3 19.5
Growth +29.9% +13.9% −5.5% +3.9% −32.2% +5.1% −4.0% +12.2% +36.7%
7.2 9.3 10.1 9.8 12.1 8.6 8.8 8.0 8.8 12.1
5.7 7.3 8.9 8.1 6.6 4.0 4.5 4.7 5.5 7.4
Growth +29.0% +21.5% −8.5% −19.2% −39.1% +12.1% +6.0% +15.2% +35.7%
1.6 1.6 1.5 1.3 0.6 0.1 0.2 1.9 1.8 2.3
17.1 19.9 18.6 14.2 9.5 9.8 8.8 7.6 7.4 7.6
−13.0 −14.2 −11.3 −7.4 −3.4 −5.9 −4.6 −4.7 −3.7 −2.5
Growth
−12.9 −14.3 −11.3 −3.5 −3.9 −5.4 −5.2 −5.0 −2.9 −3.4
−4.3 0.1 0.5 0.0 0.7 −0.3 −0.0 −0.2 0.6 −0.2
9.3 −14.3 −11.8 −3.3 −4.0 −5.1 −5.2 −4.8 −3.5 −3.2
Growth −254.5%
Per share
n/a n/a n/a −2.42 −2.31 −1.92 −1.52 −10.63 −2.79 −1.89
n/a n/a n/a n/a n/a −1.92 −1.52 −10.63 −2.79 −1.89
Growth
n/a n/a n/a n/a n/a 0.0 3.4 0.5 1.2 1.7
n/a n/a n/a n/a n/a 0.0 3.4 0.5 1.2 1.7
Growth +127,830.6% −86.6% +172.7% +35.7%

† The diluted share count jumps at 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 0.9% a year over five years.
  • Operating margin is up 5.9 points on five years ago, at -12.6%.
  • A net loss in 9 of 10 years on file.